AG真人官方

On 28鈥�29 Jul 2025, AmeriServ Financial (ASRV) EVP & CFO Michael D. Lynch bought a total of 3,500 common shares in two open-market purchases: 1,500 shares at $2.825 and 2,000 shares at $2.874. No shares were sold, and no derivative activity was reported. Lynch鈥檚 direct holding now stands at 17,832 shares, up from 14,332. The purchases represent an aggregate investment of roughly $9.9 thousand. While insider buying by a senior officer can be viewed as a confidence signal, the dollar amount is small relative to the bank鈥檚 market value, limiting the transaction鈥檚 market impact.

Quest Diagnostics Inc. (DGX) has filed a Form 144 indicating an intended sale of 8,269 common shares through Fidelity Brokerage Services.

• Aggregate market value: $1,384,230.60 (based on the market price on the filing date).
• Percentage of shares outstanding: approx. 0.0074 % of the 111,823,441 shares outstanding 鈥� an immaterial level.
• Anticipated sale date: 07 / 30 / 2025 on the NYSE.
• Source of shares: options granted on 18 Feb 2019 (3,045 shares) and 18 Feb 2020 (5,224 shares); cash was paid upon exercise.

No shares were sold during the prior three months, and the signer represents no undisclosed adverse information. The filer鈥檚 name, relationship to the issuer, and 10b5-1 plan data were not disclosed in the excerpt.

Form 144 filed for Shimmick Corp. (SHIM) discloses that insider Mitchell B. Goldsteen intends to sell 3,800 common shares on or about 25 Jul 2025 through TD Securities (USA) LLC on Nasdaq. At an assumed price of $2.08, the shares are valued at $7,910. Shimmick has 34.36 million shares outstanding, so the planned sale equals roughly 0.01 % of the float.

The filing also lists Goldsteen鈥檚 recent activity: ~255,000 shares sold between 28 Apr 2025 and 24 Jul 2025, generating gross proceeds of about $0.46 million. Cumulatively, those sales represent roughly 0.74 % of shares outstanding.

Rule 144 sales are routine for insiders but a continued cadence of dispositions may be interpreted by investors as a modest negative sentiment indicator. No new information on Shimmick鈥檚 operations, earnings, or strategic outlook is provided in this notice.

Form 144 filed for Shimmick Corp. (SHIM) discloses that insider Mitchell B. Goldsteen intends to sell 3,800 common shares on or about 25 Jul 2025 through TD Securities (USA) LLC on Nasdaq. At an assumed price of $2.08, the shares are valued at $7,910. Shimmick has 34.36 million shares outstanding, so the planned sale equals roughly 0.01 % of the float.

The filing also lists Goldsteen鈥檚 recent activity: ~255,000 shares sold between 28 Apr 2025 and 24 Jul 2025, generating gross proceeds of about $0.46 million. Cumulatively, those sales represent roughly 0.74 % of shares outstanding.

Rule 144 sales are routine for insiders but a continued cadence of dispositions may be interpreted by investors as a modest negative sentiment indicator. No new information on Shimmick鈥檚 operations, earnings, or strategic outlook is provided in this notice.

Amaze Holdings, Inc. (NYSE American: AMZE) filed an Item 3.02 Form 8-K reporting a private placement completed between 7 July and 23 July 2025.

• Securities sold: 444,040 common shares
• Cash received: US $2,601,011 (鈮� $5.86 per share)
• Commitment shares: 2,468 additional shares issued to the investor
• Purchaser: C/M Capital Master Fund, LP
• Documentation: Transaction governed by the Securities Purchase Agreement dated 6 May 2025, previously disclosed on 7 May 2025
• Registration status: Shares issued under the Section 4(a)(2)/Rule 506(b) private-offering exemption; not registered with the SEC

The filing provides no updated financials or guidance. Proceeds strengthen liquidity, but the issuance adds to share count and may dilute existing holders. No other material events were disclosed.

SM Energy Company (SM) filed a Form 4 reporting that Senior Vice President 鈥� Texas Blake Douglas McKenna received 12,481 restricted stock units (RSUs) on 25 Jul 2025. Each RSU entitles the holder to one share of common stock.

The award carries no exercise price and vests in three equal annual installments beginning 1 Jul 2026. Upon this grant, McKenna holds 12,481 derivative securities directly; no open-market purchases or sales of SM common shares were disclosed.

This appears to be routine equity compensation rather than an active investment decision. While it modestly aligns executive and shareholder interests, the transaction is unlikely to affect near-term valuation or trading dynamics.

On 07/21/2025, Quest Diagnostics Inc. (DGX) executive Mark E. Delaney, SVP & Chief Commercial Officer, reported acquiring 17 common shares at $167.491 each through a dividend reinvestment plan, a transaction eligible for deferred Form 5 reporting but voluntarily disclosed early on this Form 4. After the purchase, Delaney directly owns 7,515 DGX shares. No derivative securities were involved, and the filing indicates a routine, non-material change in insider ownership.

On 07/21/2025, Quest Diagnostics Inc. (DGX) executive Mark E. Delaney, SVP & Chief Commercial Officer, reported acquiring 17 common shares at $167.491 each through a dividend reinvestment plan, a transaction eligible for deferred Form 5 reporting but voluntarily disclosed early on this Form 4. After the purchase, Delaney directly owns 7,515 DGX shares. No derivative securities were involved, and the filing indicates a routine, non-material change in insider ownership.

Valvoline Inc. (VVV) Form 4 filing: On 07/24/2025 President & CEO Lori Ann Flees acquired 50 Deferred Stock Units (DSUs) at an implied $35.45 through the company鈥檚 2016 Deferred Compensation Plan. The transaction reflects a routine salary-deferral, not an open-market buy. After the credit, Flees directly owns 9,928 DSUs. No non-derivative share activity was reported, and no changes were disclosed to her existing common-stock position.